Regulation of Mitochondrial Biogenesis and Function by DsbA-L in the Liver
DsbA-L 在肝脏中对线粒体生物发生和功能的调节
基本信息
- 批准号:9901527
- 负责人:
- 金额:$ 33.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal ModelBindingBinding SitesBiogenesisBiologyCardiovascular DiseasesCellsChronicCyclic GMPDNADNA PackagingDNA biosynthesisDeacetylationDevelopmentDietDown-RegulationEnergy MetabolismEpidemicEscherichia coliFatty LiverGlutathione S-TransferaseGrantHepaticHepatocyteHigh Fat DietHomeostasisImpairmentIn VitroInflammationInflammatoryInsulinInsulin ResistanceKnock-outKnowledgeLeadLightLinkLipidsLiverLiver DysfunctionLiver MitochondriaLiver diseasesMediatingMetabolicMetabolic DiseasesMetabolic dysfunctionMitochondriaMitochondrial DNAMitochondrial MatrixMolecularMolecular ChaperonesMusNamesNon-Insulin-Dependent Diabetes MellitusObese MiceObesityOxidation-ReductionOxidoreductasePathway interactionsPhysiologicalPlayProtein AcetylationProtein DeficiencyProteinsRattusRegulationResearchResistanceRoleSterilityStressStructureTestingadenoviral-mediateddisulfide bondenzyme activityfactor Again of functionhuman subjectin vivoknockout animalliver functionmitochondrial dysfunctionmtTF1 transcription factormutantnovel therapeutic interventionnovel therapeuticsoverexpressionpreventprotein expressiontherapy resistanttranscription factor
项目摘要
Abstract
Mitochondria in hepatocytes play a major role in maintaining whole-body energy metabolism and normal
function of the liver. Impaired mitochondrial function is closely associated with various metabolic diseases such
as obesity, insulin resistance, and hepatosteatosis. However, the precise underlying mechanisms remain to be
fully elucidated. Filling this major gap of knowledge will yield new information on the mechanisms underlying
mitochondrial dysfunction-associated liver diseases, insulin resistance, and type 2 diabetes.
Our current study focuses on the functional roles and mechanisms of action of the disulfide-bond-A
oxidoreductase-like protein (DsbA-L). We recently found that DsbA-L expression is significantly reduced in the
liver of obese human subjects and diet-induced obese mice. In addition, loss- and gain-of-function studies
reveal that DsbA-L is a key regulator of mitochondrial integrity and function and its deficiency in the liver plays
an important role in obesity-induced hepatosteatosis and metabolic dysfunction. In the current study, we will use
molecular and cellular approaches as well as knockout animal models to elucidate the mechanisms regulating
mitochondrial integrity and function under physiological and pathophysiological conditions. This research should
shed new light on the link between obesity, mitochondrial impairment, and liver dysfunction and further our
understanding of the mechanisms underlying obesity-induced insulin resistance and metabolic diseases. Thus,
our proposed studies should provide valuable information on the biology of DsbA-L potentially being useful as
targets of anti-obesity and anti-insulin resistance therapeutics.
摘要
肝细胞中的线粒体在维持全身能量代谢和正常
肝脏的功能。线粒体功能受损与各种代谢疾病密切相关,
肥胖、胰岛素抵抗和脂肪肝。然而,确切的基本机制仍有待于
充分阐明。填补这一重大知识空白将产生关于其机制的新信息
线粒体功能障碍相关的肝脏疾病、胰岛素抵抗和2型糖尿病。
我们目前的研究重点是二硫键-A的功能作用和作用机制
氧化还原酶样蛋白(DsbA-L)。我们最近发现,DsbA-L表达显著减少,
肥胖人类受试者和饮食诱导的肥胖小鼠的肝脏。此外,功能丧失和获得研究
表明DsbA-L是线粒体完整性和功能的关键调节因子,其在肝脏中的缺乏起着重要作用。
在肥胖引起的脂肪肝和代谢功能障碍中起重要作用。在本研究中,我们将使用
分子和细胞的方法以及敲除动物模型,以阐明调节机制,
线粒体的完整性和功能在生理和病理生理条件下。这项研究应该
揭示了肥胖、线粒体损伤和肝功能障碍之间的联系,
了解肥胖引起的胰岛素抵抗和代谢性疾病的机制。因此,在本发明中,
我们提出的研究应该提供关于DsbA-L生物学的有价值的信息,
抗肥胖和抗胰岛素抵抗治疗的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN FRAZER其他文献
ALAN FRAZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN FRAZER', 18)}}的其他基金
Regulation of Mitochondrial Biogenesis and Function by DsbA-L in the Liver
DsbA-L 在肝脏中对线粒体生物发生和功能的调节
- 批准号:
10251019 - 财政年份:2018
- 资助金额:
$ 33.98万 - 项目类别:
Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats
治疗 PTSD 和抑郁症:大鼠药物治疗和心理治疗的机制
- 批准号:
9234977 - 财政年份:2017
- 资助金额:
$ 33.98万 - 项目类别:
miRNA contributes to epigenetic regulation of NR2B gene during ethanol withdrawal
乙醇戒断期间 miRNA 有助于 NR2B 基因的表观遗传调控
- 批准号:
8734304 - 财政年份:2013
- 资助金额:
$ 33.98万 - 项目类别:
Selective negative allosteric modulators of alpha 5-GABAA receptors: novel psychotherapeutic drugs
α 5-GABAA 受体的选择性负变构调节剂:新型精神治疗药物
- 批准号:
9894634 - 财政年份:2011
- 资助金额:
$ 33.98万 - 项目类别:
5-HT transporter function: Interaction of hormones and antidepressants
5-HT 转运蛋白功能:激素和抗抑郁药的相互作用
- 批准号:
8397527 - 财政年份:2011
- 资助金额:
$ 33.98万 - 项目类别:
5-HT transporter function: Interaction of hormones and antidepressants
5-HT 转运蛋白功能:激素和抗抑郁药的相互作用
- 批准号:
8043303 - 财政年份:2011
- 资助金额:
$ 33.98万 - 项目类别:
5-HT transporter function: Interaction of hormones and antidepressants
5-HT 转运蛋白功能:激素和抗抑郁药的相互作用
- 批准号:
8246298 - 财政年份:2011
- 资助金额:
$ 33.98万 - 项目类别:
5-HT transporter function: Interaction of antidepressants and hormones
5-HT 转运蛋白功能:抗抑郁药和激素的相互作用
- 批准号:
7986197 - 财政年份:2010
- 资助金额:
$ 33.98万 - 项目类别:
5-HT transporter function: Interaction of antidepressants and hormones
5-HT 转运蛋白功能:抗抑郁药和激素的相互作用
- 批准号:
8073658 - 财政年份:2010
- 资助金额:
$ 33.98万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists